Literature DB >> 18171225

Bacteremic complications of intravascular catheters colonized with Staphylococcus aureus.

Miquel B Ekkelenkamp1, Tjomme van der Bruggen, David A M C van de Vijver, Tom F W Wolfs, Marc J M Bonten.   

Abstract

Patients with Staphylococcus aureus colonization of an intravascular catheter but without demonstrated bacteremia within 24 h after intravascular catheter removal had a 24% (12 of 49 patients) chance of subsequent S. aureus bacteremia if they did not receive immediate antistaphylococcal antibiotics. Treatment within 24 h after intravascular catheter removal led to a 83% reduction in the incidence of subsequent bacteremia.

Entities:  

Mesh：

Year:  2008        PMID： 18171225     DOI： 10.1086/524077

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  9 in total

1.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

2.  The risk of catheter-related bloodstream infection after withdrawal of colonized catheters is low.

Authors:  M Guembe; M Rodríguez-Créixems; P Martín-Rabadán; L Alcalá; P Muñoz; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-31       Impact factor: 3.267

3.  Dwindling Utilization of Central Venous Catheter Tip Cultures: An Analysis of Sampling Trends and Clinical Utility at 128 US Hospitals, 2009-2014.

Authors:  Yi Ling Lai; Jennifer Adjemian; Emily E Ricotta; Lauren Mathew; Naomi P O'Grady; Sameer S Kadri
Journal:  Clin Infect Dis       Date:  2019-10-30       Impact factor: 9.079

4.  Significance of the isolation of Staphylococcus aureus from a central venous catheter tip in the absence of concomitant bacteremia: a clinical approach.

Authors:  F López-Medrano; J Lora-Tamayo; M Fernández-Ruiz; I Losada; P Hernández; M Cepeda; R San Juan; F Chaves; J M Aguado
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-01       Impact factor: 3.267

5.  Primary Staphylococcus aureus urinary tract infection: the role of undetected hematogenous seeding of the urinary tract.

Authors:  I G Baraboutis; E P Tsagalou; J L Lepinski; I Papakonstantinou; V Papastamopoulos; A T Skoutelis; S Johnson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-30       Impact factor: 3.267

Review 6.  A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill.

Authors:  Jean-François Timsit; Mark Rupp; Emilio Bouza; Vineet Chopra; Tarja Kärpänen; Kevin Laupland; Thiago Lisboa; Leonard Mermel; Olivier Mimoz; Jean-Jacques Parienti; Garyphalia Poulakou; Bertrand Souweine; Walter Zingg
Journal:  Intensive Care Med       Date:  2018-05-12       Impact factor: 17.440

7.  Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals?

Authors:  Alfonso Pérez-Parra; Patricia Muñoz; Jesús Guinea; Pablo Martín-Rabadán; María Guembe; Emilio Bouza
Journal:  Intensive Care Med       Date:  2009-02-11       Impact factor: 17.440

8.  Bacteremic complications of intravascular catheter tip colonization with Gram-negative micro-organisms in patients without preceding bacteremia.

Authors:  A van Eck van der Sluijs; J J Oosterheert; M B Ekkelenkamp; I M Hoepelman; Edgar J G Peters
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-10       Impact factor: 3.267

9.  Whole-genome sequencing to explore nosocomial transmission and virulence in neonatal methicillin-susceptible Staphylococcus aureus bacteremia.

Authors:  Bibi C G C Slingerland; Margreet C Vos; Willeke Bras; René F Kornelisse; Dieter De Coninck; Alex van Belkum; Irwin K M Reiss; Wil H F Goessens; Corné H W Klaassen; Nelianne J Verkaik
Journal:  Antimicrob Resist Infect Control       Date:  2020-02-22       Impact factor: 4.887
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.